Street Calls of the Week
SWK Holdings Corporation (NASDAQ:SWKH) reported Wednesday the full repayment of its loan to Elutia, Inc. after receiving a $27.8 million payoff. The payment included the outstanding principal, exit fees, and accrued interest, according to a press release statement based on the company’s filing with the Securities and Exchange Commission.
The repayment follows Elutia’s previously announced sale of its BioEnvelope business to Boston Scientific Corporation for $88.0 million in cash.
SWK Holdings stated that the $27.8 million payoff exceeds its net GAAP carrying value of $23.9 million for the loan as of June 30, 2025. The company expects to recognize approximately $1.4 million of incremental income from the accelerated recognition of exit fees and an additional $1.4 million from the release of loan loss reserves.
SWK Holdings is a specialty finance company focused on the life sciences sector. The company’s common stock and 9.00% Senior Notes due 2027 are listed on The Nasdaq Stock Market LLC under the symbols SWKH and SWKHL, respectively.
All information is based on a press release statement contained in the company’s latest SEC filing.
In other recent news, SWK Holdings Corp reported a notable performance for the second quarter of 2025, exceeding earnings expectations. The company achieved an earnings per share of $0.38, which is a 58.33% increase over the anticipated $0.24. This earnings surprise comes amid strategic asset sales and efforts to reduce operational costs. Despite the positive earnings report, the stock saw a decline. Analysts had projected the earnings, and the company’s performance outpaced these forecasts. These developments highlight the company’s current financial activities and strategic decisions. Investors and analysts are closely watching these recent changes.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.